title: Percutaneous coronary intervention for acute coronary syndromes: no difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding.
authors.affiliation: New York University School of Medicine, New York, NY 10016, USA.
authors.forename: Anuradha
authors.initials: A
authors.lastname: Lala
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Berger